Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Finished Goods: 2018-2019

  • Niagen Bioscience's Finished Goods rose 99.06% to $4.9 million in Q4 2019 from the same period last year, while for Dec 2019 it was $4.9 million, marking a year-over-year increase of 99.06%. This contributed to the annual value of $4.9 million for FY2019, which is 99.06% up from last year.
  • Latest data reveals that Niagen Bioscience reported Finished Goods of $4.9 million as of Q4 2019, which was up 99.06% from $2.5 million recorded in Q4 2018.
  • Niagen Bioscience's Finished Goods' 5-year high stood at $4.9 million during Q4 2019, with a 5-year trough of $2.5 million in Q4 2018.
  • Its 2-year average for Finished Goods is $3.7 million, with a median of $3.7 million in 2018.
  • Data for Niagen Bioscience's Finished Goods shows a peak YoY skyrocketed of 99.06% (in 2019) over the last 5 years.
  • Quarterly analysis of 2 years shows Niagen Bioscience's Finished Goods stood at $2.5 million in 2018, then surged by 99.06% to $4.9 million in 2019.